OnSite™ Chikungunya IgM Combo Rapid Test Kit, CE, 30 Tests

The OnSite® Chikungunya IgM Combo Rapid Test CE is a lateral flow chromatographic immunoassay for the qualitative detection of IgM antibodies to Chikungunya virus (CHIKV) in human serum, plasma, or whole blood. By targeting the IgM response, the test is designed to detect recent or acute infections and helps differentiate chikungunya from other febrile illnesses such as dengue, which shares similar clinical symptoms.

This rapid assay uses recombinant antigens derived from the Chikungunya structural protein to ensure high specificity. It provides results in minutes without requiring specialized laboratory equipment, making it highly suitable for point-of-care and field testing.

Key Features

• Specimen Flexibility: Works with serum, plasma, or whole blood.
• Recombinant Antigen Technology: Derived from CHIK structural proteins for high specificity.
• IgM Detection: Identifies recent/acute CHIKV infections.
• Differential Value: Aids in distinguishing chikungunya from dengue fever.
• Clinical Accuracy:
  • Sensitivity: 90.4%
  • Specificity: 98.0% (compared with commercial ELISA)
• No Cross-Reactivity: Tested against 14 conditions, including dengue, Zika, malaria, HIV, TB, HAV, and pregnancy samples.
• No Interference: Stable results with common interfering substances such as acetaminophen, heparin, bilirubin, glucose, EDTA, sodium citrate, and others.
• Convenient Storage: Stable for 24 months at 2–30 °C.
• Simple Workflow: Easy to perform, requires minimal training, no equipment needed.

Kit Contents

• Individually sealed foil pouches with cassette + desiccant
• Capillary tubes (5 µL)
• Sample diluent (REF SB-R0066, 5 mL/bottle)
• Instructions for use

Applications

• Clinical Diagnosis: Rapid detection of recent/acute chikungunya virus infections.
• Hospitals & Clinics: Quick triage tool for febrile patients.
• Public Health Programs: Surveillance and outbreak management in endemic regions.
• Field Testing: Ideal for resource-limited or mobile healthcare settings.
• Differential Diagnosis: Supports ruling out dengue and other febrile illnesses with overlapping symptoms.

The OnSite® Chikungunya IgM Combo Rapid Test CE (R0066C) is a fast, reliable, and easy-to-use diagnostic tool for the detection of IgM antibodies to Chikungunya virus. With strong sensitivity, excellent specificity, and proven lack of cross-reactivity, it is well-suited for clinical, public health, and field use. Its ability to differentiate chikungunya from dengue and other infections makes it an essential diagnostic aid in regions where these diseases co-circulate.